Sphera Funds Management Ltd. I Mab Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$57.18 - $84.43 $2.65 Million - $3.91 Million	-46,350 Closed	0 $0
Q2 2021 Aug 17, 2021	SELL	$47.86 - $83.95 $412,170 - $722,977	-8,612 Reduced 15.67%	46,350 $3.89 Million
Q1 2021 May 17, 2021	SELL	$44.38 - $63.97 $5.63 Million - $8.12 Million	-126,858 Reduced 69.77%	54,962 $2.66 Million
Q3 2020 Nov 12, 2020	BUY	$27.46 - $47.03 $4.99 Million - $8.55 Million	181,820 New	181,820 $8.55 Million

16M

11.9K

3.5K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $130M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.